Swaziland

Swaziland country outline

Estimated Number of Current PrEP Users

200-400

Aggregate Target Number of PrEP Users from All Projects (Planned and Ongoing)

3,000-3,500

PEPFAR Target in COP 2017

1,300

Types of Delivery Projects

  • Demonstration projects
  • Implementation projects
  • Large-scale implementation initiative

*Definitions of types of projects available in the glossary below.

Drug Registration Status

  • Gilead’s Truvada (TDF/FTC) is registered and approved for prevention
  • Generic versions of TDF/FTC are not approved for prevention

Research, Demonstration and Implementation Projects

Click here for a full list of ongoing and planned research/demonstration projects in Swaziland.

Policy Framework

N/A

Funding

USAID, The Bill & Melinda Gates Foundation, PEPFAR, Nike Foundation, Heidelberg Institute of Public Health, Mylan


Eligibility Criteria
Resources for Swaziland
Glossary of Terms

Last updated April 16, 2018.

News Spotlight